Clinical Trial

Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is an Open, Single-arm, Multicenter, Prospective Phase II Study of Fuquinitinib Combined With Tegafur Gimeracil Oteracil in the Third-line Treatment of Patients With Advanced Metastatic CRC
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-04; most recent amendment 2024-04-26.
Trial Details
NCT Number NCT06255379
Lead Sponsor Guangzhou University of Traditional Chinese Medicine
Conditions Metastasis Colorectal Cancer, Colon Cancer, Rectal Cancer
Enrollment 52 participants
Start Date 2024-05-06
Primary Completion 2027-03-21 (estimated)
Study Completion 2027-03-21 (estimated)
Updated on ClinicalTrials.gov 2024-04-29